Transfection Reagent Market Analysis Report-Global Market Sales Reached USD 826 Million in 2021

1.1 Background, development history, status quo and trend of transfection reagent industry
Transfection is the process of introducing DNA, RNA or protein into eukaryotic cells for the study and regulation of gene expression. Thus, transfection techniques serve as analytical tools that facilitate the characterization of genetic function, protein synthesis, cell growth and development. Transfection assays can not only advance cell research, but also enhance drug discovery and production strategies. Similar strategies such as viral transfection or viral transduction use lentiviral particles to insert foreign substances into eukaryotic cells. Bacterial transformation is the process of horizontal gene transfer in which bacteria ingest exogenous genetic material.

The scope of downstream applications in the world and in China continues to expand, especially the rapid progress of medical technology in China, the rapid increase in the global market demand for transfection reagents, and the future development of the industry. Compared with developed regions such as the United States and Western Europe, my country's current transfection reagent market is small, but my country's medical technology is advancing rapidly, and the state's support for the medical industry is increasing. In the future, scientific research, antibody production, gene therapy, The demand for transfection reagents in fields such as organ transplantation will continue to rise rapidly. Compared with the international market, the development momentum of my country's transfection reagent industry is stronger.



1.2 Global Market Sales and Sales of Transfection Reagents (2017-2028)
The global transfection reagent market sales reached USD 826 million in 2021 and is expected to reach USD 1398 million in 2028, with a compound annual growth rate (CAGR) of 7.84% (2022-2028). In the next few years, the industry will have great uncertainty. The forecast data for 2022-2028 in this article is based on the historical development of the past few years, the opinions of industry experts, and the opinions of analysts in this article.



1.3 Analysis of the overall scale of global transfection reagents
Cell transfection refers to the delivery of exogenous nucleic acid substances (DNA or RNA) into eukaryotic cells for various cell physiology and biochemical studies. Whether it is plasmid, DNA or various RNAs (mRNA, siRNA or microRNA), it is not easy to transfer these exogenous nucleic acids into cells, they must pass through the barrier of the cell membrane to enter the cytoplasm. Transfection methods can be divided into physical transfection and chemical transfection. Physical transfection methods include electroporation, microinjection and gene gun, etc. Chemical transfection can use calcium phosphate co-precipitation, DEAE-Dx or cationic lipid-based transfection. dyeing reagents. At present, it is mainly used in the fields of basic research and drug development and production.

The global transfection reagent market sales reached USD 826 million in 2021 and is expected to reach USD 1398 million in 2028, with a compound annual growth rate (CAGR) of 7.84% (2022-2028). From a regional perspective, the Chinese market has changed rapidly in the past few years. In 2021, the market size will be 117 million US dollars, accounting for about 14% of the global market. It is expected to reach 227 million US dollars in 2028, when the global share will reach 16%. .

Major global manufacturers of transfection reagents include Thermo Fisher Scientific, Qiagen, Promega, Roche, Polyplus, Bio-Rad and Lonza Group. Among them, Thermo Fisher Scientific has the largest market share by virtue of its product advantages. In 2021, its transfection reagent production volume will reach 622 liters, accounting for 22.16% of the global total.

The transfection reagent industry is relatively concentrated. The top three producers accounted for 61% of total global production. In terms of consumption regions, North America and Europe are the core consumer markets. In 2021, these two regions consume nearly 68% of the world's transfection reagents. Major global producers are also mainly concentrated in North America and Europe.

In the future, transfection technology can be used in the construction of animal models of diseases and drug screening models, gene therapy, xenotransplantation, improvement of animal and plant varieties and production performance, production of medicinal and health proteins, and production of human antibodies. With the widespread use of transfection reagents in different fields, the demand for transfection reagents will further expand. We believe that the transfection reagent market will maintain a solid growth of 7.84% between 2022-2028. The global transfection reagent market is expected to reach USD 1.398 billion in 2028.